Latest filing published 03 Mar 2023 for Day One Biopharmaceuticals, Inc., €440k.
Filing timeline
BuySaleInsider track record
Julie Papanek Grant: trading record in brief
This profile gathers the share dealings of Julie Papanek Grant in Day One Biopharmaceuticals, Inc. Between 13 September 2022 and 1 March 2023, the trades on record add up to 27 filings.
Every open-market trade on record is a sale: 26 sales worth €26.5M. So far in 2023, the count stands at no purchases and 5 sales.
Most recently, on 3 March 2023, the filings show an open-market sale worth €440k in Day One Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julie Papanek Grant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$18.61212.5% of flowCommon StockSEC:0001209191-23-015850:0
- 1,106 shares@ US$21.690.2% of flowCommon StockSEC:0001209191-23-006945:1
- 23,894 shares@ US$21.21062.6% of flowCommon StockSEC:0001209191-23-006945:0
- 7,610 shares@ US$21.311.2% of flowCommon StockSEC:0001209191-23-001275:1
- 17,390 shares@ US$20.3551.9% of flowCommon StockSEC:0001209191-23-001275:0
- 4,358 shares@ US$22.07670.5% of flowCommon StockSEC:0001209191-22-060728:0
- 240 shares@ US$22.340.0% of flowCommon StockSEC:0001209191-22-059727:1
- 5,000 shares@ US$21.550.8% of flowCommon StockSEC:0001209191-22-059727:2
- 4,760 shares@ US$21.72130.6% of flowCommon StockSEC:0001209191-22-059727:0
- 5,000 shares@ US$20.010.8% of flowCommon StockSEC:0001209191-22-055596:1
- 5,000 shares@ US$20.04170.6% of flowCommon StockSEC:0001209191-22-055596:0
- 5,000 shares@ US$20.000.8% of flowCommon StockSEC:0001209191-22-052756:1
- 5,000 shares@ US$20.0630.6% of flowCommon StockSEC:0001209191-22-052756:0
- 1,500,000 sharesCommon StockSEC:0000899243-22-031691:2
- 6,106 shares@ US$19.290.9% of flowCommon StockSEC:0000899243-22-031691:1
- 607,497 shares@ US$18.5465.1% of flowCommon StockSEC:0000899243-22-031691:0
- 3,722 shares@ US$22.040.7% of flowCommon StockSEC:0000899243-22-031605:1
- 76,725 shares@ US$20.5712.5% of flowCommon StockSEC:0000899243-22-031605:2
- 146,404 shares@ US$19.5022.7% of flowCommon StockSEC:0000899243-22-031605:3
- 2,266 shares@ US$20.100.4% of flowCommon StockSEC:0000899243-22-031605:4
- 111,585 shares@ US$21.5313.7% of flowCommon StockSEC:0000899243-22-031605:0
- 1,003 shares@ US$25.010.2% of flowCommon StockSEC:0000899243-22-031193:1
- 105,727 shares@ US$23.6819.9% of flowCommon StockSEC:0000899243-22-031193:2
- 384 shares@ US$24.290.1% of flowCommon StockSEC:0000899243-22-031193:3
- 47,967 shares@ US$22.798.7% of flowCommon StockSEC:0000899243-22-031193:4
25 of 15 declarations
